research

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials

Authors
Publication date
1 May 2014
Publisher
'Wiley'
Doi
    View on PubMed

    Abstract

    Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106831/1/apt12735.pd

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Deep Blue Documents

      redirect
      oaioai:deepblue.lib.umich.edu:202...
      Last time updated on 20/12/2016

      Crossref

      redirect
      oaiinfo:doi/10.1111%2Fapt.12735
      Last time updated on 01/04/2019
      Sustaining member

      eScholarship - University of California

      redirect
      oaioai:escholarship.org:ark:/1303...
      Last time updated on 20/01/2025